TCR Reading Tools
How to cite item
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TCR}{24832}, author = {Roviello, G., Generali, D., Sobhani, N.}, title = {The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study}, journal = {Translational Cancer Research}, volume = {8}, number = {Suppl 2}, year = {2018}, url = {https://tcr.amegroups.org/article/view/24832} }